CN Patent

CN110938037A — 一种依拉戈利钠盐药物中间体的制备方法

Assigned to CHENGDA PHARMACEUTICALS Co Ltd · Expires 2020-03-31 · 6y expired

What this patent protects

本申请提供一种依拉戈利钠中间体的合成方案，本申请所采用的合成方案有效地控制成本，简化反应过程和操作工艺，适合于放大生产，有利于提高产品收率和生产效率，可以降低原料药中的重金属残留的风险且避免了潜在基因毒性物质的使用，工艺更加绿色安全。

USPTO Abstract

本申请提供一种依拉戈利钠中间体的合成方案，本申请所采用的合成方案有效地控制成本，简化反应过程和操作工艺，适合于放大生产，有利于提高产品收率和生产效率，可以降低原料药中的重金属残留的风险且避免了潜在基因毒性物质的使用，工艺更加绿色安全。

Drugs covered by this patent

Patent Metadata

Patent number: CN110938037A
Jurisdiction: CN
Classification: —
Expires: 2020-03-31
Drug substance claim: No
Drug product claim: No
Assignee: CHENGDA PHARMACEUTICALS Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.